Diet & Weight Loss Archive

In a 2025 study, people who followed a Mediterranean diet, reduced their calorie intake, exercised at least 150 minutes a week, and received weight-loss support lowered their diabetes risk and lost more weight than those who only followed a Mediterranean diet.

A 2025 study suggests that the nature of ultra-processed foods, not the consumption of extra calories from these foods, is what contributes to their association with excess weight gain and a greater risk for obesity.

A 2025 study suggested that people can lose more weight by eating minimally processed foods rather than ultra-processed versions, even those typically considered healthy.

In a 2025 study, skipping breakfast was associated with a 10% increased risk for metabolic syndrome, a disorder defined by having three or more of the following: abdominal obesity, high blood pressure, high blood sugar, high triglycerides, and low HDL cholesterol.

No evidence suggests that nicotine patches promote weight loss. Nicotine suppresses appetite but also raises health risks such as high blood pressure and narrowed arteries. People can talk to a doctor about medically supervised weight loss.

Women live longer than men. However, that longevity gap in the United States has increased to 5.8 years, the largest gap since 1996, according to a 2024 study. Why the widening gap? Researchers believe that in many cases, women are better than men at addressing certain health needs that contribute to longer lives, such as losing excess weight, quitting smoking, getting regular skin check-ups, and not ignoring mental health issues.

Obesity is a common, chronic disease that can harm the heart. The powerful weight-loss medications known as GLP-1s, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are now recommended as first-line therapy for eligible people, according to the American College of Cardiology. People using these drugs should work with a dietitian or nutritionist who can help them create a personalized eating plan that ensures they’re getting enough nutrients while minimizing common side effects.

Semaglutide, a GLP-1 agonist used to treat diabetes and obesity, may also help people with metabolic dysfunction–associated steatohepatitis, a severe stage of fatty liver disease, suggests a 2025 study.

A 2025 research review found that healthy adults who paired exercise with time-restricted eating lost more fat than participants who didn’t restrict their eating window—without sacrificing lean muscle tissue.